大发快三用户注册

当前位置:  首页 >> 最新重要论文

最新重要论文

CD146 bound to LCK promotes TCR signaling and anti-tumor immune response in mice, J Clin Invest, 9 Sep 2021

发布时间:2021年09月07日

Journal of clinical investigation, 7 September, 2021, DOI:

CD146 bound to LCK promotes TCR signaling and anti-tumor immune response in mice

Hongxia Duan, Lin Jing, Xiaoqing Jiang, Yanbin Ma, Daji Wang, Jianquan Xiang, Xuehui Chen, Zhenzhen Wu, Huiwen Yan, Junying Jia, Zheng Liu, Jing Feng, Mingzhao Zhu, and Xiyun Yan

Abstract

Initiation of T cell receptor (TCR) signaling involves the activation of the tyrosine kinase LCK; however, it is currently unclear how LCK is recruited and activated. Here, we have identified the membrane protein CD146 as an essential member of the TCR network for LCK activation. CD146 deficiency in T cells substantially impaired thymocyte development and peripheral activation, both of which depend on TCR signaling. CD146 was found to directly interact with the SH3 domain of coreceptor-free LCK via its cytoplasmic domain. Interestingly, CD146 was found to be present in both monomeric and dimeric forms in T cells, with the dimerized form increasing after TCR ligation. Increased dimerized CD146 recruited LCK and promoted LCK autophosphorylation. In tumor models, CD146 deficiency dramatically impaired the anti-tumor response of T cells. Together, our data reveal a previously unrecognized LCK activation mechanism for TCR initiation. We also underscore a rational intervention based on CD146 for tumor immunotherapy.

文章链接:

相关报道:/kyjz/zxdt/202109/t20210913_6200616.html

 

 

    附件下载: